251 related articles for article (PubMed ID: 26522958)
1. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia.
Brugnoli A; Napolitano F; Usiello A; Morari M
Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958
[TBL] [Abstract][Full Text] [Related]
2. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
Brugnoli A; Pisanò CA; Morari M
Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
[TBL] [Abstract][Full Text] [Related]
3. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
4. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
Paolone G; Brugnoli A; Arcuri L; Mercatelli D; Morari M
Mov Disord; 2015 Nov; 30(13):1728-38. PubMed ID: 26207892
[TBL] [Abstract][Full Text] [Related]
5. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia.
Subramaniam S; Napolitano F; Mealer RG; Kim S; Errico F; Barrow R; Shahani N; Tyagi R; Snyder SH; Usiello A
Nat Neurosci; 2011 Dec; 15(2):191-3. PubMed ID: 22179112
[TBL] [Abstract][Full Text] [Related]
6. Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels.
Bido S; Marti M; Morari M
J Neurochem; 2011 Sep; 118(6):1043-55. PubMed ID: 21740438
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
8. GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats.
Mabrouk OS; Mela F; Calcagno M; Budri M; Viaro R; Dekundy A; Parsons CG; Auberson YP; Morari M
ACS Chem Neurosci; 2013 May; 4(5):808-16. PubMed ID: 23611155
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.
Serra M; Pinna A; Costa G; Usiello A; Pasqualetti M; Avallone L; Morelli M; Napolitano F
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070217
[No Abstract] [Full Text] [Related]
10. mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter.
Santini E; Valjent E; Fisone G
Cell Cycle; 2010 Jul; 9(14):2713-8. PubMed ID: 20581466
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
Mango D; Bonito-Oliva A; Ledonne A; Cappellacci L; Petrelli R; Nisticò R; Berretta N; Fisone G; Mercuri NB
Exp Neurol; 2014 Nov; 261():733-43. PubMed ID: 25173217
[TBL] [Abstract][Full Text] [Related]
12. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
Marti M; Rodi D; Li Q; Guerrini R; Fasano S; Morella I; Tozzi A; Brambilla R; Calabresi P; Simonato M; Bezard E; Morari M
J Neurosci; 2012 Nov; 32(46):16106-19. PubMed ID: 23152595
[TBL] [Abstract][Full Text] [Related]
14. Striatal mRNA expression patterns underlying peak dose L-DOPA-induced dyskinesia in the 6-OHDA hemiparkinsonian rat.
Smith LM; Parr-Brownlie LC; Duncan EJ; Black MA; Gemmell NJ; Dearden PK; Reynolds JN
Neuroscience; 2016 Jun; 324():238-51. PubMed ID: 26968766
[TBL] [Abstract][Full Text] [Related]
15. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
Marti M; Trapella C; Morari M
J Neurochem; 2008 Dec; 107(6):1683-96. PubMed ID: 19014386
[TBL] [Abstract][Full Text] [Related]
16. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
Zhang K; Chammas C; Soghomonian JJ
Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
[TBL] [Abstract][Full Text] [Related]
17. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
18. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
Santini E; Heiman M; Greengard P; Valjent E; Fisone G
Sci Signal; 2009 Jul; 2(80):ra36. PubMed ID: 19622833
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling.
Rylander D; Recchia A; Mela F; Dekundy A; Danysz W; Cenci MA
J Pharmacol Exp Ther; 2009 Jul; 330(1):227-35. PubMed ID: 19357321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
